AW
Andrew Williamson
Angel InvestorActiveManaging Partner at Cambridge Innovation Capital
34
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Andrew Williamson.
Investment Thesis & Strategy
Andrew Williamson invests in various stages of AI/ML, Biotech, Deeptech, Fintech, and Material Science companies, leveraging his position at Cambridge Innovation Capital to identify and support innovative ventures.
Investment Activity
Deals per year over the last 4 years
6
20160
20171
20181
2019Portfolio Companies
Selected investments from their portfolio of 34 companies
R
Riverlane
Other · Series A, 0
E
EnergyHub
Cleantech · Series A, 0
F
Fluidic Analytics
Biotech · Series A, 0
C
CEDAR Audio
Other · Seed, 0
A
AudioTelligence
AI/ML · Seed, 2019
S
Sense Biodetection
Healthcare · Series A, 2018
M
Morphogen-IX
Biotech · Series A, 2016
E
Exvastat
Biotech · Seed, 2016
I
Imagen Ltd
AI/ML · Series A, 2016
S
Storm Therapeutics
Biotech · Series A, 2016
M
Microbiotica
Biotech · Series A, 2016
G
Gyroscope Therapeutics
Biotech · Series A, 2016
Frequently Asked Questions
Andrew Williamson focuses on Seed, Series A stage investments.
Related Investors
Cambridge Angels group
Cambridge, United Kingdom · 94 deals
Max Bautin
Cambridge, United Kingdom · 56 deals
Kerry Baldwin
Cambridge, United Kingdom · 56 deals
Ed Stacey
Cambridge, United Kingdom · 56 deals
Cambridge Capital Group
Cambridge, United Kingdom · 36 deals
Carol Cheung
Cambridge, United Kingdom · 31 deals